On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...